135 related articles for article (PubMed ID: 29340645)
1. A Plasma Metabolomic Signature Involving Purine Metabolism in Human Optic Atrophy 1 (OPA1)-Related Disorders.
Bocca C; Kouassi Nzoughet J; Leruez S; Amati-Bonneau P; Ferré M; Kane MS; Veyrat-Durebex C; Chao de la Barca JM; Chevrollier A; Homedan C; Verny C; Miléa D; Procaccio V; Simard G; Bonneau D; Lenaers G; Reynier P
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):185-195. PubMed ID: 29340645
[TBL] [Abstract][Full Text] [Related]
2. Targeted Metabolomics Reveals Early Dominant Optic Atrophy Signature in Optic Nerves of Opa1delTTAG/+ Mice.
Chao de la Barca JM; Simard G; Sarzi E; Chaumette T; Rousseau G; Chupin S; Gadras C; Tessier L; Ferré M; Chevrollier A; Desquiret-Dumas V; Gueguen N; Leruez S; Verny C; Miléa D; Bonneau D; Amati-Bonneau P; Procaccio V; Hamel C; Lenaers G; Reynier P; Prunier-Mirebeau D
Invest Ophthalmol Vis Sci; 2017 Feb; 58(2):812-820. PubMed ID: 28159969
[TBL] [Abstract][Full Text] [Related]
3. The Metabolomic Signature of Opa1 Deficiency in Rat Primary Cortical Neurons Shows Aspartate/Glutamate Depletion and Phospholipids Remodeling.
Chao de la Barca JM; Arrázola MS; Bocca C; Arnauné-Pelloquin L; Iuliano O; Tcherkez G; Lenaers G; Simard G; Belenguer P; Reynier P
Sci Rep; 2019 Apr; 9(1):6107. PubMed ID: 30988455
[TBL] [Abstract][Full Text] [Related]
4. Dominant optic atrophy: Culprit mitochondria in the optic nerve.
Lenaers G; Neutzner A; Le Dantec Y; Jüschke C; Xiao T; Decembrini S; Swirski S; Kieninger S; Agca C; Kim US; Reynier P; Yu-Wai-Man P; Neidhardt J; Wissinger B
Prog Retin Eye Res; 2021 Jul; 83():100935. PubMed ID: 33340656
[TBL] [Abstract][Full Text] [Related]
5. Analysis of opa1 isoforms expression and apoptosis regulation in autosomal dominant optic atrophy (ADOA) patients with mutations in the opa1 gene.
Formichi P; Radi E; Giorgi E; Gallus GN; Brunetti J; Battisti C; Rufa A; Dotti MT; Franceschini R; Bracci L; Federico A
J Neurol Sci; 2015 Apr; 351(1-2):99-108. PubMed ID: 25796301
[TBL] [Abstract][Full Text] [Related]
6. First cases of dominant optic atrophy in Saudi Arabia: report of two novel OPA1 mutations.
Galvez-Ruiz A; Neuhaus C; Bergmann C; Bolz H
J Neuroophthalmol; 2013 Dec; 33(4):349-53. PubMed ID: 24051421
[TBL] [Abstract][Full Text] [Related]
7. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
[TBL] [Abstract][Full Text] [Related]
8. OPA1 mutations associated with dominant optic atrophy influence optic nerve head size.
Barboni P; Carbonelli M; Savini G; Foscarini B; Parisi V; Valentino ML; Carta A; De Negri A; Sadun F; Zeviani M; Sadun AA; Schimpf S; Wissinger B; Carelli V
Ophthalmology; 2010 Aug; 117(8):1547-53. PubMed ID: 20417568
[TBL] [Abstract][Full Text] [Related]
9. Modelling autosomal dominant optic atrophy associated with OPA1 variants in iPSC-derived retinal ganglion cells.
Sladen PE; Jovanovic K; Guarascio R; Ottaviani D; Salsbury G; Novoselova T; Chapple JP; Yu-Wai-Man P; Cheetham ME
Hum Mol Genet; 2022 Oct; 31(20):3478-3493. PubMed ID: 35652445
[TBL] [Abstract][Full Text] [Related]
10. AFG3L2 and ACO2-Linked Dominant Optic Atrophy: Genotype-Phenotype Characterization Compared to OPA1 Patients.
Amore G; Romagnoli M; Carbonelli M; Cascavilla ML; De Negri AM; Carta A; Parisi V; Di Renzo A; Schiavi C; Lenzetti C; Zenesini C; Ormanbekova D; Palombo F; Fiorini C; Caporali L; Carelli V; Barboni P; La Morgia C
Am J Ophthalmol; 2024 Jun; 262():114-124. PubMed ID: 38278202
[TBL] [Abstract][Full Text] [Related]
11. Mutation spectrum of the OPA1 gene in a large cohort of patients with suspected dominant optic atrophy: Identification and classification of 48 novel variants.
Weisschuh N; Schimpf-Linzenbold S; Mazzola P; Kieninger S; Xiao T; Kellner U; Neuhann T; Kelbsch C; Tonagel F; Wilhelm H; Kohl S; Wissinger B
PLoS One; 2021; 16(7):e0253987. PubMed ID: 34242285
[TBL] [Abstract][Full Text] [Related]
12. OPA1-related disorders: Diversity of clinical expression, modes of inheritance and pathophysiology.
Chao de la Barca JM; Prunier-Mirebeau D; Amati-Bonneau P; Ferré M; Sarzi E; Bris C; Leruez S; Chevrollier A; Desquiret-Dumas V; Gueguen N; Verny C; Hamel C; Miléa D; Procaccio V; Bonneau D; Lenaers G; Reynier P
Neurobiol Dis; 2016 Jun; 90():20-6. PubMed ID: 26311407
[TBL] [Abstract][Full Text] [Related]
13. The Metabolomic Bioenergetic Signature of Opa1-Disrupted Mouse Embryonic Fibroblasts Highlights Aspartate Deficiency.
Bocca C; Kane MS; Veyrat-Durebex C; Chupin S; Alban J; Kouassi Nzoughet J; Le Mao M; Chao de la Barca JM; Amati-Bonneau P; Bonneau D; Procaccio V; Lenaers G; Simard G; Chevrollier A; Reynier P
Sci Rep; 2018 Aug; 8(1):11528. PubMed ID: 30068998
[TBL] [Abstract][Full Text] [Related]
14. Autophagy controls the pathogenicity of OPA1 mutations in dominant optic atrophy.
Kane MS; Alban J; Desquiret-Dumas V; Gueguen N; Ishak L; Ferre M; Amati-Bonneau P; Procaccio V; Bonneau D; Lenaers G; Reynier P; Chevrollier A
J Cell Mol Med; 2017 Oct; 21(10):2284-2297. PubMed ID: 28378518
[TBL] [Abstract][Full Text] [Related]
15. OPA1 mutations associated with dominant optic atrophy impair oxidative phosphorylation and mitochondrial fusion.
Zanna C; Ghelli A; Porcelli AM; Karbowski M; Youle RJ; Schimpf S; Wissinger B; Pinti M; Cossarizza A; Vidoni S; Valentino ML; Rugolo M; Carelli V
Brain; 2008 Feb; 131(Pt 2):352-67. PubMed ID: 18222991
[TBL] [Abstract][Full Text] [Related]
16. Neuroradiological findings expand the phenotype of OPA1-related mitochondrial dysfunction.
Roubertie A; Leboucq N; Picot MC; Nogue E; Brunel H; Le Bars E; Manes G; Angebault Prouteau C; Blanchet C; Mondain M; Chevassus H; Amati-Bonneau P; Sarzi E; Pagès M; Villain M; Meunier I; Lenaers G; Hamel CP
J Neurol Sci; 2015 Feb; 349(1-2):154-60. PubMed ID: 25641387
[TBL] [Abstract][Full Text] [Related]
17. Biallelic Optic Atrophy 1 (
Othman BA; Ong JE; Dumitrescu AV
Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741767
[TBL] [Abstract][Full Text] [Related]
18. OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.
Delettre C; Lenaers G; Pelloquin L; Belenguer P; Hamel CP
Mol Genet Metab; 2002 Feb; 75(2):97-107. PubMed ID: 11855928
[TBL] [Abstract][Full Text] [Related]
19. Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.
Lodi R; Tonon C; Valentino ML; Iotti S; Clementi V; Malucelli E; Barboni P; Longanesi L; Schimpf S; Wissinger B; Baruzzi A; Barbiroli B; Carelli V
Ann Neurol; 2004 Nov; 56(5):719-23. PubMed ID: 15505825
[TBL] [Abstract][Full Text] [Related]
20. OPA1: 516 unique variants and 831 patients registered in an updated centralized Variome database.
Le Roux B; Lenaers G; Zanlonghi X; Amati-Bonneau P; Chabrun F; Foulonneau T; Caignard A; Leruez S; Gohier P; Procaccio V; Milea D; den Dunnen JT; Reynier P; Ferré M
Orphanet J Rare Dis; 2019 Sep; 14(1):214. PubMed ID: 31500643
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
